Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Kyma Medical Technologies

Request full access

Remote Monitoring for Patients Suffering from Chronic Cardiac Disease

Petah Tikva, IsraelFounded 2008Health Tech & Medtech

About Kyma Medical Technologies

Kyma Medical Technologies, established in 2008, was a medical device company focused on developing remote patient monitoring solutions for individuals with chronic cardiac illnesses. The company was founded by engineers Assaf Bernstein and Uriel Weinstein, who had previously worked together at the biomedical company QuantomiX. The firm's operations were based in Kfar Saba, Israel, with additional offices in California.

Kyma Medical's core product was the µ-Cor System, a non-invasive, wearable device designed to monitor the early signs of congestive heart failure. This system utilizes a proprietary radio frequency (RF) technology to track fluid levels in the lungs, a critical indicator for heart failure patients. Beyond thoracic fluid content, the µ-Cor patch continuously records multiple vital signs, including electrocardiogram (ECG), heart rate, respiration rate, activity levels, and posture. The collected data is transmitted wirelessly from the wearable sensor to a gateway device and then to a remote service center for analysis by certified technicians. Proprietary algorithms analyze this data to identify patient-specific trends, and if a potential deterioration in the patient's condition is detected, the system automatically notifies the patient's medical team. This approach facilitates early intervention, aiming to reduce hospital readmissions and improve patient outcomes.

A significant milestone for the company was receiving the CE Mark approval in Europe in January 2015, which certified the µ-Cor System for monitoring thoracic fluid, ECG, and other vital signs. The company's business model centered on the sale of these sophisticated medical devices and the associated data analysis services to healthcare professionals and institutions. In October 2013, Kyma secured $10 million in a Series A funding round from investors including Elron Electronic Industries, Rafael Development Corporation, and Ganot Capital. This investment supported the continued development and commercialization of its technology. In September 2015, Kyma Medical Technologies was acquired by ZOLL Medical Corporation, a U.S.-based manufacturer of medical devices, for an upfront payment of $35 million, with additional milestone payments. The acquisition integrated Kyma into ZOLL's LifeVest division, leveraging ZOLL's global network to broaden the market reach of the µ-Cor technology.

Source: Dealroom company data

Kyma Medical Technologies in the Petah Tikva ecosystem

Live from Dealroom

The Kyma Medical Technologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇱 Israel · Petah Tikva HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Kyma Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kyma Medical Technologies on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.